ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

UC San Diego And J&J Target Chagas Disease

by Michael McCoy
January 18, 2016 | APPEARED IN VOLUME 94, ISSUE 3

Researchers at the Skaggs School of Pharmacy & Pharmaceutical Sciences at the University of California, San Diego, will work with Johnson & Johnson’s Janssen R&D unit to identify new treatments for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America. Janssen will provide a team led by Skaggs Dean James McKerrow access to its Jump-Starter library of screening compounds. McKerrow will use the school’s new robotic screening facility to test the compounds for their ability to kill the parasite.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment